Glioma is a leading cause of central nervous system malignant
tumor-associated deaths in the world. However, the molecular mechanisms for
glioma progression are still unclear, lacking effective therapeutic strategies.
Gomisin J (GomJ) is a derivative of
lignan compound, and shows regulatory effects on virus, oxidative stress and
tumor progression. However, the role of GomJ in the
meditation of
glioma progression has not been explored. In this study, we found that GomJ markedly reduced the proliferation of
glioma cell lines. Mitochondrial apoptosis was highly induced by GomJ, as evidenced by the significantly up-regulated expression of cytoplastic Cyto-c and cleaved
Caspase-3. In addition, mitochondrial membrane potential (
MMP) and oxidative stress were highly triggered in GomJ-incubated
glioma cells, accompanied with the glycolysis suppression. Importantly, we found that GomJ could dramatically reduce the expression of
hexokinase II (HKII) in
glioma cells. At the same time, the dissociation of HKII from
voltage-dependent anion channel (VDAC) in mitochondria was markedly induced by GomJ, contributing to glycolytic repression. The in vivo experiments confirmed that GomJ obviously reduced the growth of
glioma with HKII reduction and few side effects. Taken together, these results demonstrated that GomJ could inhibit the proliferation, induce apoptosis and restrain HKII-regulated glycolysis during
glioma progression. Herein, GomJ with few toxicity might be served as a potential therapeutic strategy for the treatment of
glioma in humans.